POTI', FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.601
EU - Europa 547
AS - Asia 233
OC - Oceania 3
SA - Sud America 2
Totale 2.386
Nazione #
US - Stati Uniti d'America 1.596
GB - Regno Unito 172
IT - Italia 129
SE - Svezia 103
SG - Singapore 70
CN - Cina 64
DE - Germania 52
HK - Hong Kong 46
UA - Ucraina 24
TR - Turchia 17
FR - Francia 16
BG - Bulgaria 15
FI - Finlandia 12
MY - Malesia 9
VN - Vietnam 9
ID - Indonesia 7
BE - Belgio 6
CA - Canada 4
IN - India 4
CZ - Repubblica Ceca 3
IR - Iran 3
JP - Giappone 3
AU - Australia 2
CH - Svizzera 2
IE - Irlanda 2
LT - Lituania 2
NO - Norvegia 2
AT - Austria 1
CL - Cile 1
EC - Ecuador 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
MD - Moldavia 1
MT - Malta 1
MX - Messico 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
Totale 2.386
Città #
Fairfield 253
Chandler 148
Southend 140
Woodbridge 131
Ashburn 117
Seattle 117
Houston 101
Cambridge 91
Wilmington 86
Santa Clara 77
Ann Arbor 68
Nyköping 68
Singapore 61
Dearborn 59
Modena 58
Hong Kong 46
Jacksonville 44
Beijing 15
Eugene 15
Princeton 15
Sofia 15
Izmir 14
San Diego 13
New York 11
Redwood City 11
Helsinki 10
Dong Ket 9
London 9
Milan 9
Boardman 8
Bremen 8
Fremont 8
Ferrara 7
Munich 7
Brussels 6
Falls Church 6
Jakarta 6
Chicago 5
Kunming 5
Leawood 5
Ottawa 4
Phoenix 4
Segrate 4
Shanghai 4
Ardabil 3
Bologna 3
Corciano 3
Frankfurt am Main 3
Guangzhou 3
Imola 3
Napoli 3
Zhengzhou 3
Brno 2
Cupra Marittima 2
Dallas 2
Dublin 2
Hefei 2
Livorno 2
Norwalk 2
Tokyo 2
Acton 1
Amsterdam 1
Auckland 1
Augusta 1
Bangalore 1
Canberra 1
Casalgrande 1
Cerveteri 1
Chisinau 1
Chiswick 1
Clearwater 1
Cuauhtémoc 1
Dongguan 1
Dubendorf 1
Edinburgh 1
Ergolding 1
Esslingen am Neckar 1
Forlì 1
Fuzhou 1
Grafing 1
Hebei 1
Hounslow 1
Hyderabad 1
Islington 1
Kuala Lumpur 1
Langhirano 1
Lishui 1
Los Angeles 1
Melita 1
Monmouth Junction 1
Nanchang 1
Nanjing 1
Novokuznetsk 1
Oslo 1
Parma 1
Pavia 1
Philadelphia 1
Quito 1
Redmond 1
Reggio Emilia 1
Totale 1.978
Nome #
Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit 293
'Spare' Luteinizing Hormone Receptors: Facts and Fiction. 217
KRP-203, Sphingosine 1-Phosphate Receptor Type 1 Agonist, Ameliorates Atherosclerosis in LDL-R-/- Mice. 200
Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice 199
Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R-/-) mice. 182
Osteocytes Specific GSK3 Inhibition Affects In Vitro Osteogenic Differentiation. 181
Alcohol Pattern Consumption Differently Affects the Efficiency of Macrophage Reverse Cholesterol Transport in Vivo 167
Polyphenol Health Effects on Cardiovascular and Neurodegenerative Disorders: A Review and Meta-Analysis 164
Pharmacogenetics of G-protein-coupled receptors variants: FSH receptor and infertility treatment 134
Wisp2 overexpression induced by short Teriparatide treatment affects IDG-SW3 osteogenic differentiation. 132
Muscle-to-bone crosstalk: the Wnt/-catenin pathway is a candidate mechanism mediating the signalling between C2C12 muscle cells and 2T3 osteoblasts 129
Clusterin enhances migration and invasion of prostate cancer cells through an isoform-specific Akt2/miR-190/PHLPP1 circuit. 126
Gnrh antagonists produce differential modulation of the signaling pathways mediated by gnrh receptors 120
Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice 119
Polyphenol health effects on cardiovascular disorders: myth or truth? "Le basi farmacologiche dei nutraceutici" 53
Totale 2.416
Categoria #
all - tutte 10.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.662


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020402 0 0 0 0 51 84 95 58 49 20 30 15
2020/2021567 48 24 46 65 76 70 36 37 30 60 57 18
2021/2022364 21 17 37 33 7 20 13 36 50 20 65 45
2022/2023353 46 56 35 47 36 44 6 23 35 3 12 10
2023/2024175 5 10 11 26 20 12 22 34 0 3 10 22
2024/2025191 29 11 35 33 83 0 0 0 0 0 0 0
Totale 2.416